We are committed to providing a website that is accessible to the widest possible audience. To do so, we are actively working with consultants to update the website by increasing its accessibility and usability by persons who use assistive technologies
such as automated tools, keyboard-only navigation, and screen readers.
We are working to have the website conform to the relevant standards of the Section 508 Web Accessibility Standards developed by the United States Access Board, as
well as the World Wide Web Consortium's (W3C) Web Content Accessibility Guidelines 2.1. These standards and guidelines explain how to make web content more accessible for people with disabilities. We believe that conformance with these standards and
guidelines will help make the website more user friendly for all people.
Our efforts are ongoing. While we strive to have the website adhere to these guidelines and standards, it is not always possible to do so in all areas of the website.
If, at any time, you have specific questions or concerns about the accessibility of any particular webpage, please contact WebsiteAccess@tenethealth.com so that we may be of assistance.
Twin Cities Community Hospital is the first in the county to offer SCOUT® radar localization technology to treat women diagnosed with early-stage breast cancer.
The sophisticated technology helps:
Confirmation of the tissue to be remove
Surgical planning and guidance
Instead of wires, SCOUT® uses a reflector about the size of a grain of rice. It can be placed in the tumor up to 30 days before surgery. The reflector isn't externally visible and placement does not restrict movements. The reflector is passive until
activated, when safe, nonradioactive radar waves are used to detect it.
Wire-free radar localization for breast and lymph node surgery allows for precision in locating tumors, increasing the probability of complete cancer removal and reducing the likelihood of follow-up surgeries. In addition, the ability to strategically
plan the incision may result in better cosmetic outcomes.
The nonradioactive surgical guidance technology then guides the surgeon to the precise site of the tumor and can increase the likelihood of complete tumor removal.
The advantages to patients:
Added comfort during procedure since no invasive guide wires are used
Decreased wait times between radiology and surgery
Easier localization of the breast tumor
Enhanced surgical success of targeted tumors
FDA approved for targeting other non-breast tissues, including lymph nodes and other body parts
Fewer surgical delays
Improved patient satisfaction and well-being
When tumors are accurately located during the first surgery, any additional treatments, such as chemotherapy and radiation therapy, can occur faster.
In addition to this new technology, Templeton Imaging and Selma Carlson, our Imaging partners, offer 3D mammography (breast tomosynthesis) for breast cancer screening. Breast cancer screening with tomosynthesis when combined with a conventional 2D mammography
has a 40 percent higher invasive cancer detection rate than conventional 2D mammography alone.
"This is a dialog window which overlays the main content of the page and plays an embedded YouTube video. Pressing the Close Modal button at the bottom of the modal or pressing the Escape key will close the modal and bring you back to where you were on the page.